Florian Wilfling is a research group leader at the Max-Planck Institute of Biophysics. As a graduate student and Boehringer-Ingelheim fellow, he studied the mechanisms of protein targeting from the ER to lipid droplets with Tobias Walther at Yale University. As an EMBO long-term fellow, he moved to the group of Prof. Stefan Jentsch at the Max Planck Institute of Biochemistry, where he revealed two selective autophagy pathways targeting different macromolecular machines (namely the nuclear pore complex and the clathrin-mediated endocytosis machinery).